Lack of effects of sodium 2-mercaptoethane sulfonate (mesna) on Ochratoxin A induced renal tumorigenicity following life-time oral administration of Ochratoxin A in DA and Lewis rats

Toxicology Letters

Volumn 142, Issue 1-2, 2003, Pages 19-27

  Son, Woo Chan ^a,c   Kamino, Kenji ^b   Lee, Yong Soon ^c   Kang, Kyung Sun ^c  

^a HUNTINGDON LIFE SCIENCES   (United Kingdom)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Seoul National University   (South Korea)

Author keywords

Carcinogenicity; DA rats; Kidney tumors; Lewis rats; Mesna (sodium 2 mercaptoethane sulfonate); Ochratoxin A

Indexed keywords

MESNA; OCHRATOXIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; HISTOLOGY; KIDNEY; KIDNEY INJURY; KIDNEY TUMOR; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; URETHRA;

ANIMALS; BODY WEIGHT; CARCINOGENS; FEMALE; KIDNEY NEOPLASMS; MALE; MESNA; OCHRATOXINS; ORGAN SIZE; PROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, INBRED LEW; SEX FACTORS; URETHRAL NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 0037473430     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(02)00471-X     Document Type: Article

References (24)

1. Barbara C.M., Zahid H.S., John L.M., Sally J. Mesna does not reduce cisplatin-induced nephrotoxicity in the rat. Cancer Chemother. Pharmacol. 15:1985;307-309.
2. Baudrimont I., Betbeder A.M., Gharbi A., Pfohl-Leszkowicz A., Dirheimer G., Creppy E.E. Effect of superoxide dismutase and catalase on the nephrotoxicity induced by subchronic administration of Ochratoxin A in rats. Toxicology. 89:1994;101-111.
3. Bendele A.M., Carlton W.W., Krogh P., Lillehoj E.B. Ochratoxin A carcinogenesis in the (C57BL/6J×C3H)F1 mouse. J. Natl. Cancer Inst. 75:1985;733-742.
4. Bogush T.A., Koldaeva E.Y., Smirnova G.B., Bogush E.A., Konyaeva O.I. Effect of mesna on lethal effect and hematological toxicity of taxol and vepeside on mice. Bull. Exp. Biol. Med. 132:(3):2001;869-872.
5. Boorman G.A., McDonald M.R., Imoto S., Persing R. Renal lesions induced by Ochratoxin A exposure in the F344 rat. Toxicol. Pathol. 20:1992;236-245.
6. Broke N., Phol J., Stekar J. MESNA: studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. II. Profile of action of sodium 2-mercaptoethane sulfonate (MESNA). Eur. J. Cancer Clin. Oncol. 17:1982;1155-1163.
7. Broke N., Phol J., Stekar U., Scheef W. MESNA: studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention. III. Profile of action of sodium 2-mercaptoethane sulfonate (MESNA). Eur. J. Cancer Clin. Oncol. 18:1982;1377-1387.
8. Castegnaro M., Bartsch H., Bereziat J.C., Arvela P., Michelon J., Broussollel L. Polymorphic Ochratoxin A hydroxylation in rat strains phenotyped as poor and extensive metabolizers of debrisoquine. Xenobiotica. 19:(2):1989;225-230.
9. Castegnaro M., Mohr U., Pfohl-Leszkowicz A., Esteve J., Steinmann J., Tilmann T., Michelson J., Bartsch H. Sex- and strain-specific induction of renal tumors by Ochratoxin A in rats correlates with DNA adduction. Int. J. Cancer. 77:1998;70-75.
10. Ceovic S., Plestina R., Miletic-Medved M., Stavljenic A., Miltar J., Vukelic N. Epidemiological aspects of Balkan endemic nephropathy in a typical focus in Yugoslavia. Castegnaro M., Plestina R., Dirheimer G., Chernozemsky I.N., Bartsch H. Mycotoxin, Endemic Nephropathy and Urinary Tract Tumors. 115:1991;5-10 IARC, Lyon.
11. Creppy E.E., Baudrimont I., Betbeder A.M. Prevention of nephrotoxicity of Ochratoxin A, a food contaminant. Toxicol. Letts. 82/83:1995;869-877.
12. Furukawa F., Toyokuni S., Uchida K., Inoue T., Kurokawa Y. Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate. Jpn. J. Cancer Res. 87:(9):1996;882-886.
13. Habs M.R., Schmäahl D. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (Mesna) and disodium 2,2′-dithio-bis-ethane sulfonate(Dimesna). Cancer. 51:(4):1983;606-609.
14. Hohler D. Ochratoxin A in food and feed; occurrence, legislation and mode of action. Z. Ernahrungs. 37:(1):1998;2-12.
15. Ochratoxin A. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Some Naturally Occurring Substances. 10:1976;191-197 IARC, Lyon.
16. Kanisawa M., Suzuki S. Induction of renal and hepatic tumors in mice by Ochratoxin A, a mycotoxin. Gann. 69:1978;599-600.
17. Kempf S.R., Ivankovic S. Nephrotoxicity and carcinogenic risk of cis-platin (CDDP) prevented by sodium 2-mercaptoethane-sulfonate (Mesna): experimental results. Cancer Treat. Rev. 14:1987;365-372.
18. Mashiach E., Sela S., Weinstein T., Cohen H.I., Shasha S.M., Kristal B. Mesna: a novel renoprotective antioxidant in ischaemic acute renal failure. Nephrol. Dial. Transplant. 16:(3):2001;542-551.
19. Boorman G.A. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344N Rats (Gavage Studies). 1989;91-141 US Department of Health and Human Services, National Institute of Health, Research Triangle Park, NC.
20. Obatomi D.K., Brant S., Kaler B., Anthonypillai V., Bach P.H. Reduced susceptibility of renal slices to oxidative damage. Biochem. Soc. Trans. 25:(1):1997;36S.
21. Pool B.L., Bos R.P., Niemeyer U., Theuws J.L.G., Schmäahl D. In vitro/in vivo effects of Mesna on the genotoxicity and toxicity of cyclophosphamide - a study aimed at clarifying the mechanism of Mesna's anticarcinogenic activity. Toxicol. Letts. 41:1988;49-56.
22. Purchase I.F.H., van der Watt J.J. The long-term toxicity of ochratoxin to rats. Food Cosmet. Toxicol. 9:1971;681-682.
23. SAS Institute, 1996. SAS/STAT Software: changes and enhancements through release 6.11. SAS Institute Inc., Cary, NC, USA.
24. Stetinova V., Grossmann V. Effects of known and potential antioxidants on animal models of pathological process (diabetes, gastric lesions, allergic bronchospasm). Exp. Toxicol. Pathol. 52:(5):2000;473-479.